Skip to content

Clinical trials

Phase 1/2 Fatty Liver trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Phase: Phase 1/2 Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20151
20181
20191
20211
20222
20232
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tanta University2
89bio, Inc.1
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC1
Adrian Vella1
AstraZeneca1
Bambino Gesù Hospital and Research Institute1
Corewell Health East1
Dr Adnan Agha1
Elif Oral1
Joel Lavine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver17
Non-alcoholic Fatty Liver Disease10
Liver Cirrhosis5
Liver Diseases4
Obesity4
Fibrosis3
Diabetes Mellitus, Type 22
Liver Neoplasms2
Binge Drinking1
Cardiovascular Diseases1

Trials

Showing 76 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.